Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

Abstract Background There is no doubt that genetic factors have the potential to predict the therapeutic outcomes of antidepressants in patients with major depressive disorder (MDD). This study investigated the association between genetic variants involved in serotonin signaling and brain-derived ne...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Dominika Jarčušková, Ivan Tkáč, Nataša Hlaváčová, Alena Stančáková Yaluri, Miriam Kozárová, Viera Habalová, Lucia Klimčáková, Jozef Židzik, Martin Javorský, Aneta Bednářová
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-10-01
Serija:	BMC Psychiatry
Teme:	Pharmacogenetics Depression Escitalopram Genetic Polymorphisms SLC6A4
Online dostop:	https://doi.org/10.1186/s12888-024-06162-8
Oznake:	Označite Brez oznak, prvi označite!